BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 83 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,580,938 | -11.3% | 1,621,749 | +12.7% | 0.00% | -25.0% |
Q2 2023 | $36,737,749 | +14.6% | 1,439,567 | -4.5% | 0.00% | +33.3% |
Q1 2023 | $32,069,822 | +50.2% | 1,507,749 | +109.0% | 0.00% | +50.0% |
Q4 2022 | $21,358,146 | +6.8% | 721,559 | -16.1% | 0.00% | -33.3% |
Q3 2022 | $20,000,000 | +45.1% | 859,851 | +4.7% | 0.00% | +50.0% |
Q2 2022 | $13,780,000 | +257.3% | 821,204 | +834.1% | 0.00% | +100.0% |
Q1 2022 | $3,857,000 | -57.8% | 87,917 | -41.4% | 0.00% | 0.0% |
Q4 2021 | $9,131,000 | +51.8% | 150,012 | +3.7% | 0.00% | 0.0% |
Q3 2021 | $6,015,000 | +199.3% | 144,613 | +118.4% | 0.00% | – |
Q2 2021 | $2,010,000 | +2900.0% | 66,206 | +2855.6% | 0.00% | – |
Q1 2021 | $67,000 | +8.1% | 2,240 | -35.5% | 0.00% | – |
Q4 2020 | $62,000 | -18.4% | 3,472 | -13.0% | 0.00% | – |
Q3 2020 | $76,000 | +38.2% | 3,989 | +14.8% | 0.00% | – |
Q2 2020 | $55,000 | +25.0% | 3,474 | +6.7% | 0.00% | – |
Q1 2020 | $44,000 | – | 3,255 | +32450.0% | 0.00% | – |
Q4 2019 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |